Literature DB >> 17917505

Differential impacts of adiponectin on low-grade albuminuria between obese and nonobese persons without diabetes.

Yuichiro Yano1, Satoshi Hoshide, Joji Ishikawa, Toru Hashimoto, Kazuo Eguchi, Kazuyuki Shimada, Kazuomi Kario.   

Abstract

The goal of this study was to examine the association between adiponectin and low-grade albuminuria in nondiabetic persons and whether it differed between obese and nonobese individuals. Urinary albumin excretion (UAE) was assessed by overnight collection in 157 participants. Overall, as anticipated, 24-hour systolic blood pressure and fasting glucose levels were independent determinants of UAE (beta=0.254 and 0.176, respectively, P<.05). In obese persons (body mass index [BMI] >/=25 kg/m(2); n=63), adiponectin value was a significant negative determinant of UAE (beta=-0.256, P<.05) independent of blood pressure and glucose levels, whereas in nonobese participants (n=94) it was not. In an analysis of BMI and the median value of adiponectin (9.9 microg/mL), UAE was found to be significantly higher in obese persons with low adiponectin levels than in obese persons with high adiponectin levels (9.20 vs 5.11 microg/min; P<.05), even after adjustment for age, sex, blood pressure level, and glucose level. There was an inverse association between adiponectin and low-grade albuminuria in obese nondiabetic persons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917505      PMCID: PMC8110132          DOI: 10.1111/j.1524-6175.2007.07321.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  28 in total

Review 1.  The adipose tissue--a novel endocrine organ of interest to the nephrologist.

Authors:  Andrzej Wiecek; Franciszek Kokot; Jerzy Chudek; Marcin Adamczak
Journal:  Nephrol Dial Transplant       Date:  2002-02       Impact factor: 5.992

2.  WHO reassesses appropriate body-mass index for Asian populations.

Authors:  Vivien Choo
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

3.  Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis.

Authors:  Holly Kramer; David R Jacobs; Diane Bild; Wendy Post; Mohammed F Saad; Robert Detrano; Russell Tracy; Richard Cooper; Kiang Liu
Journal:  Hypertension       Date:  2005-06-13       Impact factor: 10.190

4.  Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension.

Authors:  Costas Tsioufis; Kyriakos Dimitriadis; Dimitris Chatzis; Carmen Vasiliadou; Dimitrios Tousoulis; Vasilios Papademetriou; Pavlos Toutouzas; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  Am J Cardiol       Date:  2005-10-01       Impact factor: 2.778

5.  Early atherosclerosis in obese juveniles is associated with low serum levels of adiponectin.

Authors:  Stefan Pilz; Renate Horejsi; Reinhard Möller; Gunter Almer; Hubert Scharnagl; Tatjana Stojakovic; Roumiana Dimitrova; Gisela Weihrauch; Martin Borkenstein; Winfried Maerz; Konrad Schauenstein; Harald Mangge
Journal:  J Clin Endocrinol Metab       Date:  2005-05-31       Impact factor: 5.958

6.  Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages.

Authors:  T Yokota; K Oritani; I Takahashi; J Ishikawa; A Matsuyama; N Ouchi; S Kihara; T Funahashi; A J Tenner; Y Tomiyama; Y Matsuzawa
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

7.  Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.

Authors:  N Ouchi; S Kihara; Y Arita; K Maeda; H Kuriyama; Y Okamoto; K Hotta; M Nishida; M Takahashi; T Nakamura; S Yamashita; T Funahashi; Y Matsuzawa
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

8.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

Review 9.  Adiponectin and metabolic syndrome.

Authors:  Yuji Matsuzawa; Tohru Funahashi; Shinji Kihara; Iichiro Shimomura
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-10-09       Impact factor: 8.311

10.  Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes.

Authors:  Klaus Klausen; Knut Borch-Johnsen; Bo Feldt-Rasmussen; Gorm Jensen; Peter Clausen; Henrik Scharling; Merete Appleyard; Jan Skov Jensen
Journal:  Circulation       Date:  2004-06-21       Impact factor: 29.690

View more
  28 in total

1.  Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Authors:  Meredith C Foster; Shih-Jen Hwang; Joseph M Massaro; Udo Hoffmann; Ian H DeBoer; Sander J Robins; Ramachandran S Vasan; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-12-23       Impact factor: 5.002

Review 2.  Kidney disease and obesity: epidemiology, mechanisms and treatment.

Authors:  Niels Olsen Saraiva Câmara; Kunitoshi Iseki; Holly Kramer; Zhi-Hong Liu; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2017-01-16       Impact factor: 28.314

Review 3.  Adiponectin effects on the kidney.

Authors:  Natalie Sweiss; Kumar Sharma
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-09-05       Impact factor: 4.690

4.  Extracellular volume and glomerular filtration rate in children with chronic kidney disease.

Authors:  Alison G Abraham; Alvaro Muñoz; Susan L Furth; Bradley Warady; George J Schwartz
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

5.  Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.

Authors:  Sankar D Navaneethan; Karen R Kelly; Firas Sabbagh; Philip R Schauer; John P Kirwan; Sangeeta R Kashyap
Journal:  Obes Surg       Date:  2010-03       Impact factor: 4.129

Review 6.  Obesity in kidney disease: A heavyweight opponent.

Authors:  Raphael Jose Ferreira Felizardo; Marina Burgos da Silva; Cristhiane Favero Aguiar; Niels Olsen Saraiva Câmara
Journal:  World J Nephrol       Date:  2014-08-06

7.  Adiponectin attenuates kidney injury and fibrosis in deoxycorticosterone acetate-salt and angiotensin II-induced CKD mice.

Authors:  Mi Tian; Li Tang; Yuanyuan Wu; Srinivasan Beddhu; Yufeng Huang
Journal:  Am J Physiol Renal Physiol       Date:  2018-06-06

8.  Irisin and Visfatin Predicts Severity of Diabetic Nephropathy.

Authors:  Ramalingam Mageswari; M G Sridhar; H Nandeesha; Sreejith Parameshwaran; K V Vinod
Journal:  Indian J Clin Biochem       Date:  2018-03-21

Review 9.  Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.

Authors:  Andrew S Bomback; Philip J Klemmer
Journal:  Am J Nephrol       Date:  2009-03-20       Impact factor: 3.754

10.  Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control.

Authors:  Adriana M Hung; Christianne L Roumie; Robert A Greevy; Xulei Liu; Carlos G Grijalva; Harvey J Murff; Marie R Griffin
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-06       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.